Citation: Dw. Moskowitz, GENETIC SCREENING AND DIAGNOSIS OF DISEASE - CAMBRIDGE-HEALTHTECH-INSTITUTE 2ND ANNUAL SYMPOSIUM - GENETIC SCREENING AND DIAGNOSIS OF HUMAN-DISEASES, Molecular medicine today, 2(7), 1996, pp. 275-275
Citation: O. Winqvist et al., THE AUTOIMMUNE BASIS OF ADRENOCORTICAL DESTRUCTION IN ADDISONS-DISEASE, Molecular medicine today, 2(7), 1996, pp. 282-289
Citation: Dn. Sheppard et Ls. Ostedgaard, UNDERSTANDING HOW CYSTIC-FIBROSIS MUTATIONS CAUSE A LOSS OF C1(-) CHANNEL FUNCTION, Molecular medicine today, 2(7), 1996, pp. 290-297
Citation: P. Newham et Mj. Humphries, INTEGRIN ADHESION RECEPTORS - STRUCTURE, FUNCTION AND IMPLICATIONS FOR BIOMEDICINE, Molecular medicine today, 2(7), 1996, pp. 304-313
Citation: J. Radich, GENE QUANTIFICATION NOW - CAMBRIDGE HEALTH-CARE INSTITUTES GENE QUANTIFICATION - DIAGNOSIS, MONITORING AND DRUG DEVELOPMENT, Molecular medicine today, 2(6), 1996, pp. 228-229
Citation: Rt. Gazzinelli, MOLECULAR AND CELLULAR BASIS OF INTERLEUKIN-12 ACTIVITY IN PROPHYLAXIS AND THERAPY AGAINST INFECTIOUS-DISEASES, Molecular medicine today, 2(6), 1996, pp. 258-267
Citation: V. Glaser, RNASE L AND 2-5A TO ENHANCE ANTISENSE TECHNOLOGY AND TARGET THE DESTRUCTION OF MESSENGER-RNA, Molecular medicine today, 2(5), 1996, pp. 183-183
Citation: J. Holt, ANTISENSE THERAPEUTICS - INTERNATIONAL-BUSINESS COMMUNICATIONS - 3RD ANNUAL SYMPOSIUM ON OLIGONUCLEOTIDE-BASED AND GENE THERAPY-BASED ANTISENSE THERAPEUTICS - CORONADO, CA, USA, 15-16 FEBRUARY 1996, Molecular medicine today, 2(5), 1996, pp. 184-185